BamSEC and AlphaSense Join Forces
Learn More

TransCode Therapeutics Inc.

NASDAQ: RNAZ    
Share price (10/17/25): $15.23    
Market cap (10/17/25): $12.7 million

Indentures Filter

EX-4.1
from DEFA14A 20 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-4.2
from 8-K 22 pages Form of Placement Agent Warrant Agreement
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 18 pages Series D Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 21 pages Series C Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Prefunded Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 23 pages Form of Representative’s Warrant Agreement
12/34/56
EX-4.3
from S-1/A 20 pages Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.4
from S-1/A 20 pages Placement Agent Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.3
from S-1/A 20 pages Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.2
from S-1/A 19 pages Pre-Funded Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.2
from S-1/A 16 pages Pre-Funded Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.4
from S-1/A 13 pages Placement Agent Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.3
from S-1/A 20 pages Pre-Funded Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.2
from S-1/A 17 pages Series [A-1/a-2] Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.4
from S-1/A 13 pages Placement Agent Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.3
from S-1/A 20 pages Pre-Funded Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.2
from S-1/A 17 pages Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56